EZETIMIBE AND SIMVASTATIN

15142 reported adverse events

Drug classes: Dietary Cholesterol Absorption Inhibitor [EPC] HMG-CoA Reductase Inhibitor [EPC]

These side effects are most commonly reported by patients taking EZETIMIBE AND SIMVASTATIN:

# Side effect Count
0 NAUSEA 1013
1 DRUG INEFFECTIVE 821
2 FATIGUE 777
3 DIZZINESS 734
4 PAIN 708
5 MYALGIA 675
6 DYSPNOEA 647
7 DIARRHOEA 605
8 ASTHENIA 604
9 HEADACHE 566
See all common reactions for EZETIMIBE AND SIMVASTATIN

EZETIMIBE AND SIMVASTATIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ISCHAEMIC CARDIOMYOPATHY 54 0.0176
1 HYPERPARATHYROIDISM SECONDARY 43 0.0171
2 NEPHROGENIC ANAEMIA 69 0.0149
3 RHABDOMYOLYSIS 446 0.0107
4 ARTERIOSCLEROSIS 96 0.0102
5 DIABETIC NEUROPATHY 49 0.0099
6 HYPERLIPIDAEMIA 118 0.0099
7 ARTERIAL OCCLUSIVE DISEASE 76 0.0097
8 RENAL FAILURE CHRONIC 65 0.0084
9 CORONARY ARTERY DISEASE 255 0.0084
See all enriched reactions for EZETIMIBE AND SIMVASTATIN